Published in N Engl J Med on November 06, 1997
Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol (2006) 3.68
Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst (2009) 3.58
Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. J Acquir Immune Defic Syndr (2013) 2.78
Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer (2006) 1.94
Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group. CMAJ (1999) 1.63
Cell-mediated immune response to human papillomavirus infection. Clin Diagn Lab Immunol (2001) 1.61
Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol (2000) 1.44
Human papillomaviruses and anogenital cancers. N Engl J Med (1997) 1.44
Determinants of incidence and clearance of high-risk human papillomavirus infections in rural Rakai, Uganda. Cancer Epidemiol Biomarkers Prev (2008) 1.44
Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination. Popul Health Metr (2007) 1.39
Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2009) 1.31
Risk of cancer in persons with AIDS in Italy, 1985-1998. Br J Cancer (2003) 1.26
The interrelation of HIV, cervical human papillomavirus, and neoplasia among antenatal clinic attenders in Tanzania. Sex Transm Infect (2001) 1.24
Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study. BMC Cancer (2009) 1.23
Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis. Int J Cancer (2012) 1.23
Prevalence and Risk Factors Associated with Precancerous Cervical Cancer Lesions among HIV-Infected Women in Resource-Limited Settings. AIDS Res Treat (2012) 1.21
Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments. CMAJ (2003) 1.20
Increased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAART. AIDS (2012) 1.19
Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer. Mol Pathol (2002) 1.14
The impact of HAART on HPV-related cervical disease. Curr HIV Res (2010) 1.12
The prevalence of cervical cytology abnormalities and human papillomavirus in women infected with the human immunodeficiency virus. Infect Agent Cancer (2009) 1.10
Human Papillomavirus (HPV) type 16 and type 18 DNA Loads at Baseline and Persistence of Type-Specific Infection during a 2-year follow-up. J Infect Dis (2009) 1.09
Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. Br J Cancer (1998) 1.08
Distribution of Human Papillomavirus Genotypes among HIV-Positive and HIV-Negative Women in Cape Town, South Africa. Front Oncol (2014) 1.08
Predictors of persistent cytologic abnormalities after treatment of cervical intraepithelial neoplasia in Soweto, South Africa: a cohort study in a HIV high prevalence population. BMC Cancer (2008) 1.07
Assessing the relationship between HIV infection and cervical cancer in Côte d'Ivoire: a case-control study. BMC Infect Dis (2010) 1.05
Rapid rise in detection of human papillomavirus (HPV) infection soon after incident HIV infection among South African women. J Infect Dis (2011) 1.04
Cutaneous squamous cell carcinoma and human papillomavirus: is there an association? Dermatol Surg (2012) 1.03
Could human papillomaviruses be spread through blood? J Clin Microbiol (2005) 1.02
Increases in human papillomavirus detection during early HIV infection among women in Zimbabwe. J Infect Dis (2011) 1.01
The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents. BMC Infect Dis (2010) 1.01
A longitudinal study of HPV detection and cervical pathology in HIV infected women. Sex Transm Infect (2000) 1.00
HIV Infection Alters the Spectrum of HPV Subtypes Found in Cervical Smears and Carcinomas from Kenyan Women. Open Virol J (2013) 0.99
Assessing the influence of health literacy on HIV-positive women's cervical cancer prevention knowledge and behaviors. J Cancer Educ (2013) 0.97
Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer. Infect Immun (2008) 0.95
Association of human papillomavirus with HIV and CD4 cell count in women with high or low numbers of sex partners. Sex Transm Infect (1999) 0.95
Human papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals. Clin Diagn Lab Immunol (2003) 0.95
Detection and typing of human papillomavirus DNA in paired urine and cervical scrapes. Eur J Epidemiol (1999) 0.94
Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. Clin Vaccine Immunol (2006) 0.93
Risk factors for VIA positivity and determinants of screening attendances in Dar es Salaam, Tanzania. BMC Public Health (2012) 0.92
Anal human papillomavirus (HPV) prevalences and factors associated with abnormal anal cytology in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil. AIDS Patient Care STDS (2015) 0.90
High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum. Br J Cancer (2002) 0.90
Evaluation of 'see-see and treat' strategy and role of HIV on cervical cancer prevention in Uganda. Reprod Health (2010) 0.90
Epidemiology of HPV in HIV-positive and HIV-negative fertile women in Cameroon, West Africa. Infect Dis Obstet Gynecol (2010) 0.89
Cervical screening within HIV care: findings from an HIV-positive cohort in Ukraine. PLoS One (2012) 0.88
HPV Vaccines: today and in the Future. J Adolesc Health (2008) 0.88
Long-term cumulative detection of human papillomavirus among HIV seropositive women. AIDS (2014) 0.88
Knowledge, awareness and attitudes about cervical cancer among women attending or not an HIV treatment center in Lao PDR. BMC Cancer (2014) 0.87
Profiles of Risk Among HIV-Infected Youth in Clinic Settings. AIDS Behav (2015) 0.87
Human papillomavirus infection in HIV-1 infected women in Catalonia (Spain): implications for prevention of cervical cancer. PLoS One (2012) 0.87
Knowledge of HPV among HIV-Infected and HIV-Uninfected Adolescent Women in South Africa. J Womens Health Issues Care (2015) 0.87
Induction of CD8 T cells by vaccination with recombinant adenovirus expressing human papillomavirus type 16 E5 gene reduces tumor growth. J Virol (2000) 0.87
CD83 polymorphisms and cervical cancer risk. Gynecol Oncol (2009) 0.86
Cervical dysplasia and high-risk human papillomavirus infections among HIV-infected and HIV-uninfected adolescent females in South Africa. Infect Dis Obstet Gynecol (2014) 0.86
A matched prospective study of human immunodeficiency virus serostatus, human papillomavirus DNA, and cervical lesions detected by cytology and colposcopy. Infect Dis Obstet Gynecol (1999) 0.86
Cervical cytological changes in HIV-infected patients attending care and treatment clinic at Muhimbili National Hospital, Dar es Salaam, Tanzania. Infect Agent Cancer (2012) 0.86
Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa. J Clin Virol (2013) 0.85
Prevalence of human papilloma virus infections and cervical cytological abnormalities among Korean women with systemic lupus erythematosus. J Korean Med Sci (2010) 0.84
Transitional probability-based model for HPV clearance in HIV-1-positive adolescent females. PLoS One (2012) 0.84
High prevalence of high risk human papillomavirus-capsid antibodies in human immunodeficiency virus-seropositive men: a serological study. BMC Infect Dis (2003) 0.83
Prevalence and determinants of high-risk human papillomavirus (HPV) infection and cervical cytological abnormalities in imprisoned women. Epidemiol Infect (2007) 0.83
Double jeopardy: HIV and cervical cancer in Indian women. Int J Gynecol Cancer (2005) 0.81
Current treatment options for management of anal intraepithelial neoplasia. Onco Targets Ther (2013) 0.80
Anal Cytology and Human Papillomavirus Genotyping in Women With a History of Lower Genital Tract Neoplasia Compared With Low-Risk Women. Obstet Gynecol (2015) 0.79
Human papillomavirus 16-specific T cell responses in classic HPV-related vulvar intra-epithelial neoplasia. Determination of strongly immunogenic regions from E6 and E7 proteins. Clin Exp Immunol (2009) 0.79
Variants in interleukin family of cytokines genes influence clearance of high risk HPV in HIV-1 coinfected African-American adolescents. Hum Immunol (2013) 0.78
Maternal transmission of human papillomavirus in retinoblastoma: A possible route of transfer. Indian J Med Paediatr Oncol (2012) 0.78
Age trends in the prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Cameroon: a cross-sectional study. BMC Res Notes (2012) 0.78
Increased alpha-9 human papillomavirus species viral load in human immunodeficiency virus positive women. BMC Infect Dis (2014) 0.78
Human papillomaviruses and anogenital cancer. N Engl J Med (1998) 0.77
Cervical pap screening cytological abnormalities among HIV-infected adolescents in the LEGACY cohort. J Pediatr Adolesc Gynecol (2011) 0.77
Nested Multiplex (NMPCR) Detection of Human Papillomavirus (HPV) 16 and 18 in Pre-invasive Lesions and its Implication in Screening of Carcinoma Cervix (CaCx). J Clin Diagn Res (2014) 0.77
HLA-A alleles and the risk of cervical squamous cell carcinoma in Japanese women. J Epidemiol (2010) 0.77
Polymorphisms in 9q32 and TSCOT are linked to cervical cancer in affected sib-pairs with high mean age at diagnosis. Hum Genet (2008) 0.77
Oral Lopinavir Use and Human Papillomavirus Infection in HIV-Positive Women. J Acquir Immune Defic Syndr (2015) 0.77
HPV clearance in postpartum period of HIV-positive and negative women: a prospective follow-up study. BMC Infect Dis (2013) 0.77
High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men. J Clin Microbiol (2005) 0.76
The combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinoma. Clin Med Insights Oncol (2011) 0.76
Usefulness of serum mass spectrometry to identify women diagnosed with higher grades of cervical intraepithelial neoplasia may differ by race. Int J Womens Health (2011) 0.76
Prevalence of and Associated Risk Factors for High Risk Human Papillomavirus among Sexually Active Women, Swaziland. PLoS One (2017) 0.75
High risk human papillomavirus persistence among HIV-infected young women in South Africa. Int J Infect Dis (2015) 0.75
Colposcopic Study of Lower Genital Tract Infections in HIV-Positive Women on Antiretroviral Therapy. J Obstet Gynaecol India (2016) 0.75
HPV Vaccine Awareness and Knowledge Among Women Living with HIV. J Cancer Educ (2016) 0.75
High Prevalence of Human Papillomavirus Infection among Brazilian Pregnant Women with and without Human Immunodeficiency Virus Type 1. Obstet Gynecol Int (2009) 0.75
Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study. BMJ Open (2016) 0.75
Sociodemographic and clinical factors of women with HPV and their association with HIV. Rev Lat Am Enfermagem (2015) 0.75
Mycoplasma hominis and Mycoplasma genitalium in the Vaginal Microbiota and Persistent High-Risk Human Papillomavirus Infection. Front Public Health (2017) 0.75
Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa. AIDS (2001) 5.84
HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA (2000) 3.93
HIV-1 seroconversion in patients with and without genital ulcer disease. A prospective study. Ann Intern Med (1993) 3.78
Substance use and high-risk sex among men who have sex with men: a national online study in the USA. AIDS Care (2004) 3.44
The impact of the Safe Kids/Healthy Neighborhoods Injury Prevention Program in Harlem, 1988 through 1991. Am J Public Health (1994) 3.39
Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. JAMA (2001) 3.26
Heterosexually transmitted human immunodeficiency virus infection among pregnant women in a rural Florida community. N Engl J Med (1992) 3.08
Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA (2000) 2.80
The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N Engl J Med (1989) 2.58
Relation between ambient air pollution and low birth weight in the Northeastern United States. Environ Health Perspect (2001) 2.44
Low-income neighborhoods and the risk of severe pediatric injury: a small-area analysis in northern Manhattan. Am J Public Health (1994) 2.36
Women at a sexually transmitted disease clinic who reported same-sex contact: their HIV seroprevalence and risk behaviors. Am J Public Health (1995) 2.34
Epidemiology of women with AIDS in the United States, 1981 through 1990. A comparison with heterosexual men with AIDS. JAMA (1991) 2.19
Peripherally inserted central catheter-related deep vein thrombosis: contemporary patterns and predictors. J Thromb Haemost (2014) 2.18
Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. J Natl Cancer Inst (1977) 2.15
Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis (1999) 2.07
Possible nosocomial transmission of HIV. Lancet (1994) 2.05
Investigations of AIDS patients with no previously identified risk factors. JAMA (1988) 1.83
Evaluation of the Hybrid Capture human papillomavirus deoxyribonucleic acid detection test. Am J Obstet Gynecol (1995) 1.80
Acquired immunodeficiency syndrome in children: report of the Centers for Disease Control National Surveillance, 1982 to 1985. Pediatrics (1987) 1.76
The association between cigarette smoking and selected HIV-related medical conditions. AIDS (1996) 1.72
Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer (2000) 1.67
Codon-dependent conformational change of elongation factor Tu preceding GTP hydrolysis on the ribosome. EMBO J (1995) 1.67
Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study. Obstet Gynecol (1994) 1.65
Risk factors in military recruits positive for HIV antibody. N Engl J Med (1986) 1.64
Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst (2000) 1.62
Association between human papillomavirus type and clonal status of cervical squamous intraepithelial lesions. J Natl Cancer Inst (1996) 1.57
Smoking practices in the black township population of Cape Town. S Afr Med J (1989) 1.57
Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. JAMA (1992) 1.51
Cell-free virus in breast milk of HIV-1-seropositive women. J Acquir Immune Defic Syndr (2000) 1.50
A polymerase chain reaction-enzyme-linked immunosorbent assay method for detecting human papillomavirus in cervical carcinomas and high-grade cervical cancer precursors. Obstet Gynecol (1995) 1.50
Involving women in HIV vaccine efficacy trials: lessons learned from a vaccine preparedness study in New York City. J Urban Health (2000) 1.47
Initial binding of the elongation factor Tu.GTP.aminoacyl-tRNA complex preceding codon recognition on the ribosome. J Biol Chem (1996) 1.47
Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. J Infect Dis (2004) 1.43
Quantitation of human immunodeficiency virus type 1 in breast milk. J Clin Microbiol (2003) 1.42
Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration. Am J Obstet Gynecol (2001) 1.39
Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretions. J Infect Dis (2001) 1.38
Loop electrosurgical excision procedure for CIN. Am Fam Physician (1992) 1.38
A cost-effective training tool for flexor tendon repair: pig's trotters. J Plast Reconstr Aesthet Surg (2006) 1.38
Improved methods for culturing rat glomerular cells. Kidney Int (1984) 1.36
Binding and internalization of heparin by vascular smooth muscle cells. J Cell Physiol (1985) 1.35
Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix. J Infect Dis (2000) 1.33
Acceptability of self-collection of specimens for HPV DNA testing in an urban population. J Womens Health (Larchmt) (2005) 1.30
Pregnancy-associated deaths due to AIDS in the United States. JAMA (1989) 1.30
A neglected lesbian health concern: cervical neoplasia. J Fam Pract (1996) 1.29
Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis. Mol Cell Probes (1992) 1.29
Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL. J Fam Pract (1998) 1.27
Controversies in the management of low-grade cervical intraepithelial neoplasia. Cancer (1993) 1.26
Are HIV-infected women who breastfeed at increased risk of mortality? AIDS (2001) 1.26
Peyer's patches: immunologic studies. J Exp Med (1970) 1.26
Oral replacement therapy in rural Bangladesh with home ingredients. Trop Doct (1981) 1.24
The effects of vitamin A supplementation on the morbidity of children born to HIV-infected women. Am J Public Health (1995) 1.24
Size and shape of mineralites in young bovine bone measured by atomic force microscopy. Calcif Tissue Int (2003) 1.24
Shape and size of isolated bone mineralites measured using atomic force microscopy. J Orthop Res (2001) 1.23
Chlamydia trachomatis and Pap testing from a single, fluid-based sample. A multicenter study. J Reprod Med (2001) 1.20
Regulation of vascular smooth muscle cell growth by heparin and heparan sulfates. Semin Thromb Hemost (1987) 1.20
Differential subtraction chain, a method for identifying differences in genomic DNA and mRNA. Nucleic Acids Res (1999) 1.18
Transmission of HIV in Belle Glade, Florida: lessons for other communities in the United States. Science (1988) 1.17
Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy? J Fam Pract (1998) 1.17
Retaining hard-to-reach women in HIV prevention and vaccine trials: Project ACHIEVE. Am J Public Health (2001) 1.17
Assessment of the cervix after acetic acid wash: inter-rater agreement using photographs. Obstet Gynecol (2002) 1.16
Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells. J Cell Biol (1989) 1.15
Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission. J Infect Dis (2001) 1.15
Overview and implementation of an intervention to prevent adherence failure among HIV-infected adults initiating antiretroviral therapy: lessons learned from Project HEART. AIDS Care (2006) 1.13
Isolation and characterization of the mycobacterial phagosome: segregation from the endosomal/lysosomal pathway. Mol Microbiol (1997) 1.12
Conventional cervical cytologic smears vs. ThinPrep smears. A paired comparison study on cervical cytology. Acta Cytol (1997) 1.12
Molecular biology of cervical cancer and its precursors. Cancer (1995) 1.11
Rates of aggregation, loss of anchorage dependence, and tumorigenicity of cultured cells. Proc Natl Acad Sci U S A (1977) 1.11
The epidemic of AIDS and HIV-1 infection among heterosexuals in New York City. AIDS (1990) 1.11
Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstet Gynecol (1995) 1.11
Exclusive breast-feeding: does it have the potential to reduce breast-feeding transmission of HIV-1? Nutr Rev (2000) 1.07
Inhibition of rat cervical epithelial cell growth by heparin and its reversal by EGF. J Cell Physiol (1985) 1.07
Diagnostic performance of Hybrid Capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study. Am J Obstet Gynecol (1996) 1.05
Tissue response to the STOP microcoil transcervical permanent contraceptive device: results from a prehysterectomy study. Fertil Steril (2001) 1.02
Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells. Cell Regul (1990) 1.01
Highway cowboys, old hands, and Christian truckers: risk behavior for human immunodeficiency virus infection among long-haul truckers in Florida. Soc Sci Med (2000) 1.00
Diversity of risk of mother-to-child HIV-1 transmission according to feeding practices, CD4 cell count, and haemoglobin concentration in a South African cohort. Trop Med Int Health (2008) 1.00
Cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus: outcome after loop electrosurgical excision. Gynecol Oncol (1994) 1.00
Screening for depressive symptoms in an online sample of men who have sex with men. AIDS Care (2008) 1.00
Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus. Am J Med (2001) 0.97
Toward an objective classification of cells in the immune system. Proc Natl Acad Sci U S A (1988) 0.96
Increased adhesiveness of Down syndrome fetal fibroblasts in vitro. Proc Natl Acad Sci U S A (1984) 0.96
Prevalence of anal human papillomavirus infection and anal cytologic abnormalities in HIV-seropositive women. AIDS (1996) 0.95